Nicox Ophthalmics
Nicox Ophthalmics develops therapeutics from a proprietary nitric-oxide research platform to help maintain vision and improve ocular health.
Company Location
4819 Emperor Blvd., Suite 400
Durham
NC
27703
Phone
County
Region
Company Details
Company type
Year founded
1996
Employment range in NC
US headquarters
North Carolina
Global headquarters
France
Primary site activity
All company activities
Products on market
VYZULTA® in glaucoma, licensed exclusively worldwide to Bausch + Lomb, is commercialized in more than 15 countries, including the U.S.; ZERVIATE® in allergic conjunctivitis is commercialized in the U.S. by Harrow Health Inc.
Products under development
NCX 470 in Phase 3 clinical development for IOP lowering for patients with open-angle glaucoma and ocular hypertension; NCX 1728 in preclinical development for retinal conditions